Coral Laboratories (CORALAB) | Stock Overview & Key Data
Coral Laboratories Performance Comparison
Stock Range
Today's Range
Low: ₹480.00
High: ₹489.00
on August 20, 2025
52 Week Range
Low: ₹471.00
High: ₹999.00
on August 19, 2025
on September 12, 2024
All-Time High: ₹1,190.00 on July 24, 2017
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR1.7B
EPS
67.61
P/E Ratio (TTM)
7.14
Forward P/E
8.30
P/B Ratio
0.86
PEG Ratio
8.30
Div. Yield
0.34%
ROE
12.01%
Beta
0.676
Debt to Equity
1.77
Financial Highlights
Profitability
Gross Margin
48.21%
Operating Margin
9.19%
Profit Margin
17.54%
Returns and Earnings
Return on Assets (TTM)
10.53%
Return on Equity (TTM)
12.01%
EBITDA
INR353.5M
Net Income (TTM)
INR179.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR285.98
Quarterly Revenue Growth (YoY)
-40.50%
Quarterly Earnings Growth (YoY)
-70.90%
Dividend Information
Last 12-Month Dividend
₹2.00
Current Dividend Yield
0.34%
3-Year Average Dividend Yield
0.22%
3-Year Average Annual Dividend
₹0.67
3-Year Total Dividends
₹2.00
Ex-Dividend Date
September 20, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Coral Laboratories CORALAB | 1.72B Small-cap | -13.11% | -17.08% | -34.91% | -38.74% | -40.76% | -46.90% | 89.29% | 59.31% |
| Sun Pharmaceutical SUNPHARMA | 3.94T Large-cap | 0.27% | -3.88% | -5.99% | -2.98% | -13.93% | -8.40% | 84.81% | 192.69% |
| Divi's Laboratories DIVISLAB | 1.64T Large-cap | 1.99% | -9.10% | -7.61% | 2.44% | 0.11% | 25.20% | 69.46% | 85.76% |
| Sun Pharma Advanced SPARC | 45.51B Small-cap | 4.19% | -8.09% | -11.48% | 12.35% | -26.33% | -34.00% | -36.71% | -22.67% |
| Aarti Drugs AARTIDRUGS | 44.80B Small-cap | 0.27% | -9.96% | 2.11% | 28.03% | 7.74% | -12.97% | 12.03% | -33.03% |
| Sequent Scientific SEQUENT | 43.92B Small-cap | 1.51% | -5.78% | -0.25% | 17.84% | -4.22% | 5.62% | 52.82% | 30.86% |
Ownership & Short Interest
Insider Ownership
78.46%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
2K
Average 90-Day Volume
1K
Coral Laboratories Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Coral Laboratories would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CORALAB's 52-week high and low?
- In the last 52 weeks, Coral Laboratories reached a high of ₹999.00 (on September 12, 2024) and a low of ₹471.00 (on August 19, 2025).
- What is the market cap and P/E ratio for CORALAB?
- Curious about Coral Laboratories's size and valuation? Its market capitalization stands at 1.72B. When it comes to valuation, the P/E ratio (trailing twelve months) is 7.14, and the forward P/E (looking ahead) is 8.30.
- Does CORALAB pay dividends? If so, what's the yield?
- Yes, Coral Laboratories is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.34%, and the company has paid an average of ₹0.67 per share annually over the past 3 years.
- Who are Coral Laboratories's main competitors or similar companies to consider before investing?
When looking at Coral Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.94T Healthcare Drug Manufacturers - Specialty & Generic -8.40% 84.81% Divi's Laboratories
DIVISLAB1.64T Healthcare Drug Manufacturers - Specialty & Generic 25.20% 69.46% Sun Pharma Advanced
SPARC45.51B Healthcare Drug Manufacturers - Specialty & Generic -34.00% -36.71% Aarti Drugs
AARTIDRUGS44.80B Healthcare Drug Manufacturers - Specialty & Generic -12.97% 12.03% Sequent Scientific
SEQUENT43.92B Healthcare Drug Manufacturers - Specialty & Generic 5.62% 52.82% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Coral Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Coral Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.01%, the Debt to Equity ratio from the most recent quarter is 1.77, and its Gross Profit Margin stands at 48.21%.
- What is the recent revenue and earnings growth for CORALAB?
- Looking at Coral Laboratories's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by -40.50%, and quarterly earnings saw a YoY growth of -70.90%.
- How much of CORALAB stock is held by insiders and institutions?
- Wondering who owns Coral Laboratories stock? Company insiders (like executives and directors) hold about 78.46% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.